Reprogramming in vivo produces teratomas and iPS cells with totipotency features
Open accessThe DOI matches its Crossref record; 46 of the 46 references it cites were found in a registry or an index.
Abstract
Reprogramming of adult cells to generate induced pluripotent stem cells (iPS cells) has opened new therapeutic opportunities; however, little is known about the possibility of in vivo reprogramming within tissues. Here we show that transitory induction of the four factors Oct4, Sox2, Klf4 and c-Myc in mice results in teratomas emerging from multiple organs, implying that full reprogramming can occur in vivo. Analyses of the stomach, intestine, pancreas and kidney reveal groups of dedifferentiated cells that express the pluripotency marker NANOG, indicative of in situ reprogramming. By bone marrow transplantation, we demonstrate that haematopoietic cells can also be reprogrammed in vivo. Notably, reprogrammable mice present circulating iPS cells in the blood and, at the transcriptome level, these in vivo generated iPS cells are closer to embryonic stem cells (ES cells) than standard in vitro generated iPS cells. Moreover, in vivo iPS cells efficiently contribute to the trophectoderm lineage, suggesting that they achieve a more plastic or primitive state than ES cells. Finally, intraperitoneal injection of in vivo iPS cells generates embryo-like structures that express embryonic and extraembryonic markers. We conclude that reprogramming in vivo is feasible and confers totipotency features absent in standard iPS or ES cells. These discoveries could be relevant for future applications of reprogramming in regenerative medicine.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Continuous expression of all four factors in normal mice, however, often induces teratomas17–19 or is fatal within days16, ostensibly due to tissue dysplasia18.”
From Reprogramming to recover youthful epigenetic information and restore vision (2020) · cites this paper as [18]
In the citing paper
“Teratoma formation has been observed in partially reprogrammed animals, particularly when c-Myc is used in the partial rejuvenation cocktail (Abad et al., 2013; Ocampo et al., 2016; Ohnishi et al., 2014; Senís et al., 2018)”
From Gene Therapy-Mediated Partial Reprogramming Extends Lifespan and Reverses Age-Related Changes in Aged Mice (2024) · cites this paper as Abad et al., 2013
In the citing paper
“cellular reprogramming to pluripotency, although associated with tumor development (e.g., teratoma formation), can be achieved in vivo in mice by the forced expression of the Yamanaka factors”
From In Vivo Amelioration of Age-Associated Hallmarks by Partial Reprogramming. (2016) · cites this paper as Abad et al., 2013
In the citing paper
“Although previous studies have indicated that expression of the Yamanaka factors in vivo can lead to cancer development or teratoma formation (Abad et al., 2013;Ohnishi et al., 2014), here, we demonstrate that tumor formation can be avoided by short-term induction of OSKM.”
From In Vivo Amelioration of Age-Associated Hallmarks by Partial Reprogramming. (2016) · cites this paper as Abad et al., 2013
In the citing paper
“The Yamanaka factors possess oncogenic properties, which can lead to teratoma formation when persistently overexpressed in vivo (Abad et al., 2013; Ohnishi et al., 2014).”
From Multi-omic rejuvenation of human cells by maturation phase transient reprogramming (2022) · cites this paper as Abad et al., 2013
4 more claims about this paper
Create a free account to see every claim other papers make about this one.
Citations
Cites
The Sequence Alignment/Map format and SAMtools
Li, H., Handsaker, B., Wysoker, A., Fennell, T., Ruan, J., Homer, N., Marth, G., Abecasis, G., Durbin, R., & 1000 Genome Project Data Processing Subgroup (2009) · Bioinformatics · doi:10.1093/bioinformatics/btp352 · Cited by 62,041
Takahashi, K., & Yamanaka, S. (2006) · Cell · doi:10.1016/j.cell.2006.07.024 · Cited by 26,673
Ultrafast and memory-efficient alignment of short DNA sequences to the human genome.
Langmead, B., Trapnell, C., Pop, M., & Salzberg, S. L. (2009) · Genome Biology · doi:10.1186/gb-2009-10-3-r25 · Cited by 21,849
Trapnell, C., Roberts, A., Goff, L., Pertea, G., Kim, D., Kelley, D. R., Pimentel, H., Salzberg, S. L., Rinn, J. L., & Pachter, L. (2012) · Nature Protocols · doi:10.1038/nprot.2012.016 · Cited by 12,116
In vivo reprogramming of adult pancreatic exocrine cells to β-cells
Zhou, Q., Brown, J., Kanarek, A., Rajagopal, J., & Melton, D. A. (2008) · Nature · doi:10.1038/nature07314 · Cited by 2,010
In vivo reprogramming of murine cardiac fibroblasts into induced cardiomyocytes
Qian, L., Huang, Y., Spencer, C. I., Foley, A., Vedantham, V., Liu, L., Conway, S. J., Fu, J.-D., & Srivastava, D. (2012) · Nature · doi:10.1038/nature11044 · Cited by 1,360
Heart repair by reprogramming non-myocytes with cardiac transcription factors
Song, K., Nam, Y.-J., Luo, X., Qi, X., Tan, W., Huang, G. N., Acharya, A., Smith, C. L., Tallquist, M. D., Neilson, E. G., et al. (2012) · Nature · doi:10.1038/nature11139 · Cited by 1,147
The promise of induced pluripotent stem cells in research and therapy
Robinton, D. A., & Daley, G. Q. (2012) · Nature · doi:10.1038/nature10761 · Cited by 1,111
Embryonic stem cell potency fluctuates with endogenous retrovirus activity
Macfarlan, T. S., Gifford, W. D., Driscoll, S., Lettieri, K., Rowe, H. M., Bonanomi, D., Firth, A., Singer, O., Trono, D., & Pfaff, S. L. (2012) · Nature · doi:10.1038/nature11244 · Cited by 981
Hanna, J., Cheng, A. W., Saha, K., Kim, J., Lengner, C. J., Soldner, F., Cassady, J. P., Muffat, J., Carey, B. W., & Jaenisch, R. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1004584107 · Cited by 847
The Transcriptional and Epigenomic Foundations of Ground State Pluripotency
Marks, H., Kalkan, T., Menafra, R., Denissov, S., Jones, K., Hofemeister, H., Nichols, J., Kranz, A., Francis Stewart, A., Smith, A., et al. (2012) · Cell · doi:10.1016/j.cell.2012.03.026 · Cited by 835
Koh, K. P., Yabuuchi, A., Rao, S., Huang, Y., Cunniff, K., Nardone, J., Laiho, A., Tahiliani, M., Sommer, C. A., Mostoslavsky, G., et al. (2011) · Cell Stem Cell · doi:10.1016/j.stem.2011.01.008 · Cited by 776
Hochedlinger, K., Yamada, Y., Beard, C., & Jaenisch, R. (2005) · Cell · doi:10.1016/j.cell.2005.02.018 · Cited by 747
Beddington, R. S. P., & Robertson, E. J. (1989) · Development · doi:10.1242/dev.105.4.733 · Cited by 593
Elite and stochastic models for induced pluripotent stem cell generation
Yamanaka, S. (2009) · Nature · doi:10.1038/nature08180 · Cited by 515
Reprogramming of murine and human somatic cells using a single polycistronic vector
Carey, B. W., Markoulaki, S., Hanna, J., Saha, K., Gao, Q., Mitalipova, M., & Jaenisch, R. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0811426106 · Cited by 503
Conversion of mature B cells into T cells by dedifferentiation to uncommitted progenitors
Cobaleda, C., Jochum, W., & Busslinger, M. (2007) · Nature · doi:10.1038/nature06159 · Cited by 502
Guidelines and Techniques for the Generation of Induced Pluripotent Stem Cells
Maherali, N., & Hochedlinger, K. (2008) · Cell Stem Cell · doi:10.1016/j.stem.2008.11.008 · Cited by 486
Direct conversion of fibroblasts into stably expandable neural stem cells
Thier, M., Wörsdörfer, P., Lakes, Y. B., Gorris, R., Herms, S., Opitz, T., Seiferling, D., Quandel, T., Hoffmann, P., Nöthen, M. M., et al. (2012) · Cell Stem Cell · doi:10.1016/j.stem.2012.03.003 · Cited by 447
Eminli, S., Foudi, A., Stadtfeld, M., Maherali, N., Ahfeldt, T., Mostoslavsky, G., Hock, H., & Hochedlinger, K. (2009) · Nature Genetics · doi:10.1038/ng.428 · Cited by 442
Generation of induced neurons via direct conversion in vivo
Torper, O., Pfisterer, U., Wolf, D. A., Pereira, M., Lau, S., Jakobsson, J., Björklund, A., Grealish, S., & Parmar, M. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1303829110 · Cited by 417
Agouti C57BL/6N embryonic stem cells for mouse genetic resources
Pettitt, S. J., Liang, Q., Rairdan, X. Y., Moran, J. L., Prosser, H. M., Beier, D. R., Lloyd, K. C., Bradley, A., & Skarnes, W. C. (2009) · Nature Methods · doi:10.1038/nmeth.1342 · Cited by 384
Epigenetic restriction of embryonic cell lineage fate by methylation of Elf5
Ng, R. K., Dean, W., Dawson, C., Lucifero, D., Madeja, Z., Reik, W., & Hemberger, M. (2008) · Nature Cell Biology · doi:10.1038/ncb1786 · Cited by 368
A reprogrammable mouse strain from gene-targeted embryonic stem cells
Stadtfeld, M., Maherali, N., Borkent, M., & Hochedlinger, K. (2010) · Nature Methods · doi:10.1038/nmeth.1409 · Cited by 208
Direct lineage reprogramming of post-mitotic callosal neurons into corticofugal neurons in vivo
Rouaux, C., & Arlotta, P. (2013) · Nature Cell Biology · doi:10.1038/ncb2660 · Cited by 205
Single-gene transgenic mouse strains for reprogramming adult somatic cells
Carey, B. W., Markoulaki, S., Beard, C., Hanna, J., & Jaenisch, R. (2010) · Nature Methods · doi:10.1038/nmeth.1410 · Cited by 205
Ras-MAPK signaling promotes trophectoderm formation from embryonic stem cells and mouse embryos
Lu, C.-W., Yabuuchi, A., Chen, L., Viswanathan, S., Kim, K., & Daley, G. Q. (2008) · Nature Genetics · doi:10.1038/ng.173 · Cited by 164
In vivo reprogramming of Sox9 + cells in the liver to insulin-secreting ducts
Banga, A., Akinci, E., Greder, L. V., Dutton, J. R., & Slack, J. M. W. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1201701109 · Cited by 159
Conversion of human fibroblasts to angioblast-like progenitor cells
Kurian, L., Sancho-Martinez, I., Nivet, E., Aguirre, A., Moon, K., Pendaries, C., Volle-Challier, C., Bono, F., Herbert, J.-M., Pulecio, J., et al. (2013) · Nature Methods · doi:10.1038/nmeth.2255 · Cited by 145
Festing, M., Overend, P., Das, R., Cortina‐Borja, M., & Berdoy, M. (2002) · Cited by 140
Pfister, S., Steiner, K. A., & Tam, P. (2007) · Gene Expression Patterns · doi:10.1016/j.modgep.2007.01.005 · Cited by 124
Gordon, E. J., Gale, N. W., & Harvey, N. L. (2008) · Developmental Dynamics · doi:10.1002/dvdy.21605 · Cited by 123
Advanced Protocols for Animal Transgenesis: An ISTT Manual
Pease, S., & Saunders, T. L. (2011) · Springer protocols handbooks/Springer protocols · doi:10.1007/978-3-642-20792-1 · Cited by 71
Hughes, E. D., Qu, Y. Y., Genik, S. J., Lyons, R. H., Pacheco, C. D., Lieberman, A. P., Samuelson, L. C., Nasonkin, I. O., Camper, S. A., Keuren, M. L. V., et al. (2007) · Mammalian Genome · doi:10.1007/s00335-007-9054-0 · Cited by 70
Finch, A. J., Soucek, L., Junttila, M. R., Swigart, L. B., & Evan, G. I. (2009) · Molecular and Cellular Biology · doi:10.1128/mcb.01745-08 · Cited by 63
Human Embryonic Stem Cells Form Embryoid Bodies Containing Visceral Endoderm-Like Derivatives
Conley, B. J., Trounson, A. O., & Mollard, R. (2004) · Fetal Diagnosis and Therapy · doi:10.1159/000076701 · Cited by 58
Assou, S., Boumela, I., Haouzi, D., Monzo, C., Déchaud, H., Kadoch, I.-J., & Hamamah, S. (2012) · PLoS ONE · doi:10.1371/journal.pone.0039306 · Cited by 56
The Design of Animal Experiments
Festing, M. F. W. (2010) · The UFAW Handbook on the Care and Management of Laboratory and Other Research Animals · doi:10.1002/9781444318777.ch3 · Cited by 49
Glover, C. H., Marin, M., Eaves, C. J., Helgason, C. D., Piret, J. M., & Bryan, J. (2006) · PLoS Computational Biology · doi:10.1371/journal.pcbi.0020158 · Cited by 45
Haenebalcke, L., Goossens, S., Dierickx, P., Bartunkova, S., D’Hont, J., Haigh, K., Hochepied, T., Wirth, D., Nagy, A., & Haigh, J. J. (2013) · Cell Reports · doi:10.1016/j.celrep.2013.01.016 · Cited by 41
Gene walking by unpredictably primed PCR
Domínguez, O., & López‐Larrea, C. (1994) · Nucleic Acids Research · doi:10.1093/nar/22.15.3247 · Cited by 38
Self-citationYao, X.-Q., Li, X.-C., Zhang, X.-X., Yin, Y.-Y., Liu, B., Luo, D.-J., Wang, Q., Wang, J.-Z., & Liu, G.-P. (2012) · FEBS Letters · doi:10.1016/j.febslet.2012.06.018 · Cited by 37
Advanced protocols for animal transgenesis : an ISTT manual
Pease, S., & Saunders, T. L. (2011) · Cited by 34
A Cre‐reporter transgenic mouse expressing the far‐red fluorescent protein Katushka
Diéguez‐Hurtado, R., Martín‐Broto, J., Martínez‐Corral, I., Martínez, M. D., Megías, D., Olmeda, D., & Ortega, S. (2010) · genesis · doi:10.1002/dvg.20685 · Cited by 32
Self-citationSelf-organizing circuitry and emergent computation in mouse embryonic stem cells
Halley, J. D., Smith‐Miles, K., Winkler, D. A., Kalkan, T., Huang, S., & Smith, A. G. (2011) · Stem Cell Research · doi:10.1016/j.scr.2011.11.001 · Cited by 21
Koo, T. B., Song, H., Moon, I., Han, K., Chen, C., MURPHY, K. M. M., & Lim, H. J. (2005) · Reproduction · doi:10.1530/rep.1.00656 · Cited by 16
Cited by
Cellular Senescence: Aging, Cancer, and Injury
Calcinotto, A., Kohli, J., Zagato, E., Pellegrini, L., Demaria, M., & Alimonti, A. (2019) · Physiological Reviews · doi:10.1152/physrev.00020.2018 · Cited by 1,270
“Despite this, in vivo reprogramming efficiencies are still very low (2), and therefore, intrinsic reprogramming barriers must also exist in vivo.”
BackgroundIn Vivo Amelioration of Age-Associated Hallmarks by Partial Reprogramming.
Ocampo, A., Reddy, P., Martinez-Redondo, P., Platero-Luengo, A., Hatanaka, F., Hishida, T., Li, M., Lam, D., Kurita, M., Beyret, E., et al. (2016) · Cell · doi:10.1016/j.cell.2016.11.052 · Cited by 988
“Cyclic In Vivo Induction of Reprogramming Factors Does Not Lead to Tumor Formation Previous studies have shown that the in vivo induction of OSKM leads to teratoma formation and the development of cancer (Abad et al., 2013; Ohnishi et al., 2014).”
InfluentialReprogramming to recover youthful epigenetic information and restore vision
Lu, Y., Brommer, B., Tian, X., Krishnan, A., Meer, M., Wang, C., Vera, D. L., Zeng, Q., Yu, D., Bonkowski, M. S., et al. (2020) · Nature · doi:10.1038/s41586-020-2975-4 · Cited by 820
Epigenetic regulation of aging: implications for interventions of aging and diseases
Wang, K., Liu, H., Hu, Q., Wang, L., Liu, J., Zheng, Z., Zhang, W., Ren, J., Zhu, F., & Liu, G.-H. (2022) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-022-01211-8 · Cited by 663
Advanced drug delivery systems and artificial skin grafts for skin wound healing
Kim, H. S., Sun, X., Lee, J.-H., Kim, H.-W., Fu, X., & Leong, K. W. (2019) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2018.12.014 · Cited by 625
Metadata
- Authors
- Abad, M., Mosteiro, L., Pantoja, C., Cañamero, M., Rayon, T., Ors, I., Graña, O., Megías, D., Domínguez, O., Martínez, D., Manzanares, M., Ortega, S., & Serrano, M.
- Affiliations
- Spanish National Cancer Research Centre (ES)
- Spanish National Centre for Cardiovascular Research (ES)
- Corresponding author
- Serrano, Manuel
- Venue
- Nature
- Published
- 2013-09-11
- Volume
- 502
- Issue
- 7471
- Pages
- 340-345
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- OpenAlex
- W2051454588
- Cited by
- 547
- References
- 46
- Citations by year
- 2026: 30 · 2025: 37 · 2024: 41 · 2023: 46 · 2022: 51 · 2021: 46 · 2020: 47 · 2019: 35 · 2018: 38 · 2017: 47 · 2016: 26 · 2015: 38 · 2014: 54 · 2013: 11
- FWCI
- 19.25
- Type
- journal article
- Language
- en
- Open access
- green
- hdl.handle.net
- Licence
- cc-by-nc-nd
- www.springer.com/tdm (tdm)
- www.springer.com/tdm (vor)
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- RePEc: Research Papers in Economics (submittedVersion)
- CEU Repositorio Institucional (Fundación Universitaria San Pablo CEU) (submittedVersion, cc-by-nc-nd)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Pluripotent Stem Cells Research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Developmental Biology and Gene Regulation
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Mesenchymal stem cell research
- Keywords
- in vivo reprogramming, induced pluripotent stem cells, teratoma, totipotency, Yamanaka factors, Oct4, SOX2, KLF4, c-Myc, Nanog, trophectoderm, embryonic stem cells, regenerative medicine
- MeSH terms
- Kruppel-Like Factor 4, Animals, Blood Cells, Cell Separation, Cells, Cultured, Ectoderm, Female, Fibroblasts, Intestines, Kidney, Male, Mice, Inbred C57BL, Organ Specificity, Pancreas, Stomach, Teratoma, Trophoblasts, Proto-Oncogene Proteins c-myc, Gene Expression Profiling, Totipotent Stem Cells, Octamer Transcription Factor-3, Mice, Kruppel-Like Transcription Factors, Embryonic Stem Cells, Cell Dedifferentiation, SOXB1 Transcription Factors, Induced Pluripotent Stem Cells, Embryoid Bodies, Transcriptome, Cellular Reprogramming
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.